Legend Biotech (LEGN) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Legend Biotech (LEGN) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Legend Biotech

· LEGN

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

3.647 B

+5.69%

General

Market Cap: $3.65B
Enterprise Value: $3.28B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 56.58%
Operating Margin: -4.42%
Net Profit Margin: -7.21%
FCF Margin: -20.10%
ROA: -5.23%
ROE: -8.70%
ROIC: -3.71%
Current Ratio: 3.04
Debt-to-Equity: 0.23
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 2.89
P/FCF: —
P/B: 2.99
EV/EBITDA: -453.31

Growth

Rev 1Y: 64.04%
Rev 1Y Fwd Est: 39.83%
Rev 3Y (CAGR): 106.41%
Rev 5Y (CAGR): 68.83%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $1.27B
Gross Margin: 56.58%
Operating Expenses: $775.4M
Operating Income: -$56.15M
Net Profit: -$91.6M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $672.92M
Working Capital: $823.83M
Total Assets: $1.75B
Net Debt: -$394.71M
Total Liabilities: $521.32M
Total Equity: $1.23B

Cash Flow Statement (TTM)

Cash Flow from Operations: -$183.1M
Cash Flow from Investing: $331.72M
Cash Flow from Financing: $166.52M
Free Cash Flow: -$255.58M
Capital Expenditures: $72.49M